Investigational Device Exemption (IDE) Overview for IRBs

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
Chapter 1 The Study of Body Function Image PowerPoint
1 Balloting/Handling Negative Votes September 11, 2006 ASTM Training Session Bob Morgan Brynn Iwanowski.
1 Balloting/Handling Negative Votes September 22 nd and 24 th, 2009 ASTM Virtual Training Session Christine DeJong Joe Koury.
Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
606 CMR 14.00: Background Record Checks What you need to know!
FACTORING ax2 + bx + c Think “unfoil” Work down, Show all steps.
Site Safety Plans PFN ME 35B.
Engagement in Human Research & Multi-Site Studies K. Lynn Cates, M.D. Assistant Chief Research & Development Officer Director, PRIDE May 30, 2012.
REVIEW: Arthropod ID. 1. Name the subphylum. 2. Name the subphylum. 3. Name the order.
EMS Checklist (ISO model)
1 HSPP Overview – IRB Members (Boards 1, 2, 3) University of Illinois at Chicago Office for the Protection of Research Subjects Charles Hoehne, Education.
Regulatory Pathway for Platform Technologies
Investigational Device Exemptions 21 CFR Part 812
IRB Process & Medical Devices
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Overview of FDA Device Regulations
Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
Barbara Gibson, MS, RN, CCRC, CIP, CHRC Regulatory Affairs Officer Vanderbilt Human Research Protection Program.
Replacement Reagent Policy Update
VOORBLAD.
Checking & Corrective Action
The Radioactive Drug Research Committee Approval Process for Tracer Use Anthony F. Shields, M.D., Ph.D. Karmanos Cancer Institute Wayne State University.
Factor P 16 8(8-5ab) 4(d² + 4) 3rs(2r – s) 15cd(1 + 2cd) 8(4a² + 3b²)
Carole C. Carey, BSEE, M.Engineering Director, International Staff
© 2012 National Heart Foundation of Australia. Slide 2.
Dullien Associates, LLC
Understanding Generalist Practice, 5e, Kirst-Ashman/Hull
25 seconds left…...
Januar MDMDFSSMDMDFSSS
Internal Control and Control Risk
What is involved? What are your responsibilities? May 2013: Research Institute, Clinical Research Administration Investigational New Drug Application (IND)
We will resume in: 25 Minutes.
©Brooks/Cole, 2001 Chapter 12 Derived Types-- Enumerated, Structure and Union.
PSSA Preparation.
IRB Review of Device Research and Other Clinical Uses of Devices
Special Topics in IND Regulation
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
Regulatory Considerations for Investigational Assays: Planning for Success Elizabeth Mansfield, PhD OIVD/FDA “Next-Generation DNA Sequencing as a Tool.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
Investigational New Drug Application (IND)
Medical Devices IRB Determination IRB Member Continuing Education.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Investigational Devices and Humanitarian Use Devices June 2007.
Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring.
Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.
Drug Development and IND Process GC 690 Walter Kraft, MD.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
GCP AND MEDICAL DEVICES
What Are the FDA Requirements for Submitting an IDE?
Andrew Farb, MD and Dorothy Abel, BSBME
How to Put Together an IDE Application
Device Review Decision Tree Version Date: 4/28/15 This decision tree to be used for studies involving research on a device ( approved or unapproved)
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Streamlining IRB Procedures for Expanded Access
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Opening an IND: Investigator Perspective
Research with Human Subjects
Presentation transcript:

Investigational Device Exemption (IDE) Overview for IRBs Marian Serge, RN Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health FDA

Topics Provision of IDE regulations Medical device definition When is an IDE not needed When is an IDE required Significant risk (SR) device Non-significant risk (NSR) device Non compliance

Provisions of the IDE Regulation - 21 CFR 812 Submission process of an IDE application to FDA for significant risk device studies Process for obtaining IDE for non-significant risk device studies Assigns responsibilities: sponsor and clinical investigator Investigator agreement Device accountability Reporting and records IRB review and informed consent

IRBs must know three basic things Does the study involve a device? Does it need an IDE? Is the device SR or NSR?

Question # 1 What is a device?

What is a medical device? An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent . . .or component, part, or accessory. . . intended to diagnose a disease or condition or to cure, mitigate, treat, or for prevention of disease or it affects the structure or function of the body…..and does not achieve its primary purpose through chemical action. . . or by being metabolized

Question 2 Does the device study require an Investigational Device Exemption (IDE)?

Is an Investigational Device Exemption (IDE) Needed? “No” Practice of medicine Basic physiological research Exempt studies [21 CFR 812.2(c)] “Yes” Studies that support research or marketing applications Investigation that collect safety and effectiveness Studies of new indications

IDE not needed

Practice of Medicine (no IDE) Physician should Be well informed about the product Use firm scientific rationale and sound medical evidence Maintain records on use and effects Not research but check Institutional policy: it may require IRB review and Informed Consent

Basic Physiological Research (no IDE) Investigating a physiological principle No intent to develop the device for marketing Only using the device to address the research question – not safety and effectiveness

Exempt Studies (exempt from 21 CFR 812) (no IDE) Description of exempt devices [21 CFR 812.2(c)] Approved devices used in accordance with labeling Most in vitro diagnostic devices (IVDs) Consumer preference testing, testing of a minor modification, testing of a combination of approved devices FDA post approval studies

IDE required

Studies that support research or marketing (IDE required) Significant risk device research Submission of an Investigational Device Exemption (IDE) application to FDA Follow all of 21 CFR 812 Non-significant risk device research IRB approval; after which the study is considered to have an IDE Follow only 21 CFR 812.2(b)

Results of an investigation to FDA (IDE needed) Clinical investigations of devices where safety and effectiveness data are collected will require an IDE

Studies of new indications (IDE needed) New intended use of an approved device Different age population New disease or condition Different body placement Changing from ‘treatment’ to ‘prevention’ for the same disease Also, new materials or design used in approved devices

Where’s the Line? IDE NO IDE Studies of investigational devices (support research or marketing applications) Studies of new indications NO IDE Practice of Medicine Basic physiological research Exempt studies Studying a cleared/approved device w/in label

Question 3 Is the device SR or NSR?

Significant Risk Device Definition Intended as an implant and presents a potential serious risk to the health, safety, or welfare of a subject Or

Significant Risk Device Definition Is purported or represented to be for a use in supporting or sustaining human life and presents a potential serious risk to the health, safety, or welfare of a subject Or

Significant Risk Device Definition Is for a use of substantial importance in diagnosing, curing, mitigating, or treating disease, or otherwise preventing impairment of human health and presents a potential serious risk to the health, safety, or welfare of a subject Or

Significant Risk Device Definition Otherwise presents a potential for serious risk to the health safety or welfare of the subject Examples of SR devices: stents, respirators, dialysis machines, sutures, organ storage units, dental lasers for hard tissue, deep brain stimulators, female condoms, etc

Significant Risk Device IDEs Sponsor submits IDE application to FDA FDA approves or disapproves or FDA conditionally approves which means there are no safety concerns and the study can begin while deficiencies are being addressed After FDA approval and IRB approval the SR device study can begin

Non-significant risk device Any device that is not significant risk Examples: caries removal solution contact lens, daily wear gastroenterology and urology endoscopes and/or accessories externally worn monitors for insulin reactions

Non-significant risk device IDEs Sponsor presents the IRB with protocol & a brief explanation why the device is not a significant risk device IRB also determines whether the device is SR or NSR If IRB determination agrees with sponsor’s NSR determination the IRB can review and approve the study using the criterial at 21CFR 56.111 it is considered to have approved application for IDE No formal IDE submission to FDA

Quick summary SR and NSR device studies Significant risk device study Requires FDA and IRB approval Non-significant risk device study Requires IRB approval Need help deciding? CDRH has procedures: see handout. Want to see FDA’s decision letter? Ask the sponsor.

IRB Non-compliance Inadequate initial or continuing review Frequency of review Expedited review SR determination Inadequate records SOPs Minutes, including the vote Membership roster Study documentation

Clinical Investigator Non-compliance Failed to Follow investigational plan, investigator agreement, or protocol Document case history and device exposure Obtain adequate informed consent

Clinical Investigator Non-compliance Failed to Control of investigational device Report Unanticipated ADEs Obtain FDA or IRB approval to conduct study

Summary Medical device definition Significant risk (SR) device Non-significant risk (NSR) device IDE not required IDE required IRB and investigator non-compliance

IDE Staff Websites: Sheila.Brown@fda.hhs.gov Stephen Rhodes, Director Contact Information and Websites IDE Staff Sheila.Brown@fda.hhs.gov Stephen Rhodes, Director Websites: www.fda.gov and click on Medical Devices www.fda.gov/oc/ohrt/irbs/

Marian Serge, RN DBM, OC, CDRH, FDA Marian,Serge@FDA.HHS.GOV (301) 796-5644